STERIS (STE) Stock Analysis & Winston Score
STERIS plc makes products and services that keep medical equipment clean and safe to use. Its core business is sterilization — killing germs on surgical tools, medical devices, and hospital supplies so patients don't get infections. The company sells sterilization equipment, cleaning chemicals, and outsourced sterilization services mainly to hospitals, surgery centers, and medical device manufacturers. STERIS makes money through a mix of equipment sales, consumable supplies that customers reorder regularly, and long-term service contracts. It operates globally but generates most of its revenue in the United States, and it reported roughly $5 billion in annual revenue in recent years. Its competitive moat comes from sticky customer relationships, regulatory complexity that makes switching difficult, and a large installed base of equipment that drives recurring consumable and service revenue. The key growth driver is the steady rise in surgical procedure volumes worldwide, while the main risk is potential pricing pressure from large hospital systems and group purchasing organizations.
Winston Score: 62/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Mixed (13/30)
- Growth: Exceptional (19/20)
- Cash Flow: Exceptional (9/10)
- Stability: Exceptional (10/10)
- Valuation: Strong (7/10)
- Ownership: Weak (1/15)


